Nova Patents
IL255221D0

Heterodimeric antibodies that bind cd3 and tumor antigens

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

176 members in 38 offices

This recordMember, by publication datePriority claim28 more offices are in the list below

Priority claims18

Priority claims
DocumentOfficeKindDate
201562159111United States of AmericaP
201562250971United States of AmericaP
201562251005United States of AmericaP
2015062772United States of AmericaW
201514952714United States of AmericaA
2016029797United States of AmericaW
14952714–––
62159111–––
62250971–––
62251005–––
PCTUS2016029797–––
PCTUS2015062772–––
US201514952714–––
US201562159111P–––
US201562250971P–––
US201562251005P–––
WO2015US62772–––
WO2016US29797–––

Members176

Family members, oldest first
DocumentOfficeKind
CA2967426A1CanadaA1
CA2968878A1CanadaA1
WO2016086186A2World Intellectual Property Organization (WIPO)A2
WO2016086189A2World Intellectual Property Organization (WIPO)A2
WO2016086196A2World Intellectual Property Organization (WIPO)A2
US2016176969A1United States of AmericaA1
US2016215063A1United States of AmericaA1
US2016229924A1United States of AmericaA1
WO2016086196A3World Intellectual Property Organization (WIPO)A3
WO2016086186A3World Intellectual Property Organization (WIPO)A3
WO2016086189A3World Intellectual Property Organization (WIPO)A3
CA2984134A1CanadaA1
WO2016182751A1World Intellectual Property Organization (WIPO)A1
US2016355608A1United States of AmericaA1
US2017081420A1United States of AmericaA1
US2017081424A1United States of AmericaA1
CA3006052A1CanadaA1
WO2017091656A1World Intellectual Property Organization (WIPO)A1
AU2015353409A1AustraliaA1
AU2015353416A1AustraliaA1
SG11201704274QASingaporeA
SG11201704283PASingaporeA
KR20170084326ARepublic of KoreaA
KR20170084327ARepublic of KoreaA
IL252467A0IsraelA0
IL252467D0IsraelD0
IL252480A0IsraelA0
IL252480D0IsraelD0
PE20171103A1PeruA1
AU2017216517A1AustraliaA1
PE20171324A1PeruA1
CN107207610AChinaA
CR20170222ACosta RicaA
EP3223845A2European Patent Office (EPO)A2
EP3223907A2European Patent Office (EPO)A2
CO2017005388A2ColombiaA2
EP3236996A1European Patent Office (EPO)A1
CU20170074A7CubaA7
CU20170074A7CubaA7
CO2017005842A2ColombiaA2
AU2016262368A1AustraliaA1
PH12017500968A1PhilippinesA1
CN107406512AChinaA
SG11201708620QASingaporeA
JP2017536829AJapanA
JP2017536830AJapanA
BR112017011092A2BrazilA2
US9850320B2United States of AmericaB2
EA201791164A1Eurasian Patent Organization (EAPO)A1
IL255221A0IsraelA0
IL255221D0This recordIsraelD0
US9856327B2United States of AmericaB2
PH12017500982A1PhilippinesA1
CR20170511ACosta RicaA
PE20180188A1PeruA1
MX2017006918AMexicoA
CL2017001361A1ChileA1
KR20180018525ARepublic of KoreaA
BR112017011166A2BrazilA2
CL2017001328A1ChileA1
CL2017002752A1ChileA1
MX2017014353AMexicoA
CO2017011486A2ColombiaA2
PH12017502019A1PhilippinesA1
EA201791139A1Eurasian Patent Organization (EAPO)A1
EA201792467A1Eurasian Patent Organization (EAPO)A1
MX2017006966AMexicoA
CN108025046AChinaA
MA40663A1MoroccoA1
AU2016359683A1AustraliaA1
WO2017091656A8World Intellectual Property Organization (WIPO)A8
JP2018519263AJapanA
BR112017023943A2BrazilA2
HK1244219AHong Kong, ChinaA
HK1244219A1Hong Kong, ChinaA1
US2018223000A1United States of AmericaA1
HK1245171AHong Kong, ChinaA
HK1245171A1Hong Kong, ChinaA1
EP3380196A1European Patent Office (EPO)A1
MA43305AMoroccoA
US2018282432A1United States of AmericaA1
TN2017000222A1TunisiaA1
TN2017000223A1TunisiaA1
US2018305465A1United States of AmericaA1
MX2018006382AMexicoA
GT201700112AGuatemalaA
JP2019503661AJapanA
ECSP17040521AEcuadorA
ECSP17081420AEcuadorA
AU2019201923A1AustraliaA1
TN2017000470A1TunisiaA1
US10259887B2United States of AmericaB2
AU2015353409B2AustraliaB2
AU2016262368B2AustraliaB2
US2019202938A1United States of AmericaA1
AU2019216719A1AustraliaA1
AU2017216517B2AustraliaB2
US10526417B2United States of AmericaB2
CN110894240AChinaA
NZ732144ANew ZealandA
Showing 100 of 176